Previous GWASs on MG have identified the correlations between variants in genes (e.g., CTLA4 and PTPN22) with MG risk, which directly modulates the proportion or function of CD4+ Tregs (9, 11). This evidence concerns the gene PTPN22 and myasthenia gravis.